Table 1 General characteristics of participants
Characteristics | Herpes zoster (n, %) | Reference (n, %) | P-value* |
|---|---|---|---|
Age (years) | 1.000 | ||
20–24 | 1818 (3.1) | 7272 (3.1) | |
25–29 | 2790 (4.7) | 11,160 (4.7) | |
30–34 | 3409 (5.7) | 13,636 (5.7) | |
35–39 | 3889 (6.5) | 15,556 (6.5) | |
40–44 | 4623 (7.8) | 18,492 (7.8) | |
45–49 | 6189 (10.4) | 24,756 (10.4) | |
50–54 | 7964 (13.4) | 31,856 (13.4) | |
55–59 | 7239 (12.2) | 28,956 (12.2) | |
60–64 | 6273 (10.5) | 25,092 (10.5) | |
65–69 | 5783 (9.7) | 23,132 (9.7) | |
70–74 | 4611 (7.8) | 18,444 (7.8) | |
75–79 | 2798 (4.7) | 11,192 (4.7) | |
80–84 | 1381 (2.3) | 5524 (2.3) | |
85+ | 728 (1.2) | 2912 (1.2) | |
Sex | 1.000 | ||
Male | 23,677 (39.8) | 94,708 (39.8) | |
Female | 35,818 (60.2) | 143,272 (60.2) | |
Income | 1.000 | ||
1 (lowest) | 9048 (15.2) | 36,192 (15.2) | |
2 | 8306 (14.0) | 33,224 (14.0) | |
3 | 9840 (16.5) | 39,360 (16.5) | |
4 | 13,072 (22.0) | 52,288 (22.0) | |
5 (highest) | 19,229 (32.3) | 76,916 (32.3) | |
Region of residence | 1.000 | ||
Urban | 28,342 (47.6) | 113,368 (47.6) | |
Rural | 31,153 (52.4) | 124,612 (52.4) | |
CCI score† | < 0.001* | ||
0 | 21,182 (35.6) | 100,129 (42.1) | |
1 | 5942 (10.0) | 24,823 (10.4) | |
2 | 8187 (13.8) | 30,511 (12.8) | |
3 | 7804 (13.1) | 27,512 (11.6) | |
≥ 4 | 16,380 (27.5) | 55,005 (23.1) | |
Lymphoid neoplasm | 90 (0.15) | 212 (0.08) | < 0.001* |